TREM-1 Deficiency Can Attenuate Disease Severity without Affecting Pathogen Clearance
Triggering receptor expressed on myeloid cells-1 (TREM-1) is a potent amplifier of pro-inflammatory innate immune reactions. While TREM-1-amplified responses likely aid an improved detection and elimination of pathogens, excessive production of cytokines and oxygen radicals can also severely harm the host. Studies addressing the pathogenic role of TREM-1 during endotoxin-induced shock or microbial sepsis have so far mostly relied on the administration of TREM-1 fusion proteins or peptides representing part of the extracellular domain of TREM-1. However, binding of these agents to the yet unidentified TREM-1 ligand could also impact signaling through alternative receptors. More importantly, controversial results have been obtained regarding the requirement of TREM-1 for microbial control. To unambiguously investigate the role of TREM-1 in homeostasis and disease, we have generated mice deficient in Trem1. Trem1−/− mice are viable, fertile and show no altered hematopoietic compartment. In CD4+ T cell- and dextran sodium sulfate-induced models of colitis, Trem1−/− mice displayed significantly attenuated disease that was associated with reduced inflammatory infiltrates and diminished expression of pro-inflammatory cytokines. Trem1−/− mice also exhibited reduced neutrophilic infiltration and decreased lesion size upon infection with Leishmania major. Furthermore, reduced morbidity was observed for influenza virus-infected Trem1−/− mice. Importantly, while immune-associated pathologies were significantly reduced, Trem1−/− mice were equally capable of controlling infections with L. major, influenza virus, but also Legionella pneumophila as Trem1+/+ controls. Our results not only demonstrate an unanticipated pathogenic impact of TREM-1 during a viral and parasitic infection, but also indicate that therapeutic blocking of TREM-1 in distinct inflammatory disorders holds considerable promise by blunting excessive inflammation while preserving the capacity for microbial control.
Vyšlo v časopise:
TREM-1 Deficiency Can Attenuate Disease Severity without Affecting Pathogen Clearance. PLoS Pathog 10(1): e32767. doi:10.1371/journal.ppat.1003900
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1003900
Souhrn
Triggering receptor expressed on myeloid cells-1 (TREM-1) is a potent amplifier of pro-inflammatory innate immune reactions. While TREM-1-amplified responses likely aid an improved detection and elimination of pathogens, excessive production of cytokines and oxygen radicals can also severely harm the host. Studies addressing the pathogenic role of TREM-1 during endotoxin-induced shock or microbial sepsis have so far mostly relied on the administration of TREM-1 fusion proteins or peptides representing part of the extracellular domain of TREM-1. However, binding of these agents to the yet unidentified TREM-1 ligand could also impact signaling through alternative receptors. More importantly, controversial results have been obtained regarding the requirement of TREM-1 for microbial control. To unambiguously investigate the role of TREM-1 in homeostasis and disease, we have generated mice deficient in Trem1. Trem1−/− mice are viable, fertile and show no altered hematopoietic compartment. In CD4+ T cell- and dextran sodium sulfate-induced models of colitis, Trem1−/− mice displayed significantly attenuated disease that was associated with reduced inflammatory infiltrates and diminished expression of pro-inflammatory cytokines. Trem1−/− mice also exhibited reduced neutrophilic infiltration and decreased lesion size upon infection with Leishmania major. Furthermore, reduced morbidity was observed for influenza virus-infected Trem1−/− mice. Importantly, while immune-associated pathologies were significantly reduced, Trem1−/− mice were equally capable of controlling infections with L. major, influenza virus, but also Legionella pneumophila as Trem1+/+ controls. Our results not only demonstrate an unanticipated pathogenic impact of TREM-1 during a viral and parasitic infection, but also indicate that therapeutic blocking of TREM-1 in distinct inflammatory disorders holds considerable promise by blunting excessive inflammation while preserving the capacity for microbial control.
Zdroje
1. AllcockRJ, BarrowAD, ForbesS, BeckS, TrowsdaleJ (2003) The human TREM gene cluster at 6p21.1 encodes both activating and inhibitory single IgV domain receptors and includes NKp44. Eur J Immunol 33: 567–577.
2. FordJW, McVicarDW (2009) TREM and TREM-like receptors in inflammation and disease. Curr Opin Immunol 21: 38–46.
3. Klesney-TaitJ, TurnbullIR, ColonnaM (2006) The TREM receptor family and signal integration. Nat Immunol 7: 1266–1273.
4. BouchonA, DietrichJ, ColonnaM (2000) Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 164: 4991–4995.
5. ArtsRJ, JoostenLA, van der MeerJW, NeteaMG (2013) TREM-1: intracellular signaling pathways and interaction with pattern recognition receptors. J Leukoc Biol 93: 209–15.
6. ChungDH, SeamanWE, DawsMR (2002) Characterization of TREM-3, an activating receptor on mouse macrophages: definition of a family of single Ig domain receptors on mouse chromosome 17. Eur J Immunol 32: 59–66.
7. BarrowAD, AstoulE, FlotoA, BrookeG, RelouIA, et al. (2004) Cutting edge: TREM-like transcript-1, a platelet immunoreceptor tyrosine-based inhibition motif encoding costimulatory immunoreceptor that enhances, rather than inhibits, calcium signaling via SHP-2. J Immunol 172: 5838–5842.
8. KingRG, HerrinBR, JustementLB (2006) Trem-like transcript 2 is expressed on cells of the myeloid/granuloid and B lymphoid lineage and is up-regulated in response to inflammation. J Immunol 176: 6012–6021.
9. BouchonA, FacchettiF, WeigandMA, ColonnaM (2001) TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 410: 1103–1107.
10. RadsakMP, SalihHR, RammenseeHG, SchildH (2004) Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival. J Immunol 172: 4956–4963.
11. GibotS, Kolopp-SardaMN, BeneMC, BollaertPE, LozniewskiA, et al. (2004) A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J Exp Med 200: 1419–1426.
12. GibotS, BuonsantiC, MassinF, RomanoM, Kolopp-SardaMN, et al. (2006) Modulation of the triggering receptor expressed on the myeloid cell type 1 pathway in murine septic shock. Infect Immun 74: 2823–2830.
13. GibotS, CravoisyA, LevyB, BeneMC, FaureG, et al. (2004) Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med 350: 451–458.
14. GibotS, Kolopp-SardaMN, BeneMC, CravoisyA, LevyB, et al. (2004) Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med 141: 9–15.
15. MurakamiY, AkahoshiT, HayashiI, EndoH, KawaiS, et al. (2006) Induction of triggering receptor expressed on myeloid cells 1 in murine resident peritoneal macrophages by monosodium urate monohydrate crystals. Arthritis Rheum 54: 455–462.
16. BoscoMC, PierobonD, BlengioF, RaggiF, VanniC, et al. (2011) Hypoxia modulates the gene expression profile of immunoregulatory receptors in human mature dendritic cells: identification of TREM-1 as a novel hypoxic marker in vitro and in vivo. Blood 117: 2625–2639.
17. CollinsCE, LaDT, YangHT, MassinF, GibotS, et al. (2009) Elevated synovial expression of triggering receptor expressed on myeloid cells 1 in patients with septic arthritis or rheumatoid arthritis. Ann Rheum Dis 68: 1768–1774.
18. YasudaT, TakeyamaY, UedaT, ShinzekiM, SawaH, et al. (2008) Increased levels of soluble triggering receptor expressed on myeloid cells-1 in patients with acute pancreatitis. Crit Care Med 36: 2048–2053.
19. RadsakMP, TaubeC, HaselmayerP, TenzerS, SalihHR, et al. (2007) Soluble triggering receptor expressed on myeloid cells 1 is released in patients with stable chronic obstructive pulmonary disease. Clin Dev Immunol 2007: 52040.
20. Adib-ConquyM, MonchiM, GoulenokC, LaurentI, ThuongM, et al. (2007) Increased plasma levels of soluble triggering receptor expressed on myeloid cells 1 and procalcitonin after cardiac surgery and cardiac arrest without infection. Shock 28: 406–410.
21. SaurerL, RihsS, BirrerM, Saxer-SeculicN, RadsakM, et al. (2012) Elevated levels of serum-soluble triggering receptor expressed on myeloid cells-1 in patients with IBD do not correlate with intestinal TREM-1 mRNA expression and endoscopic disease activity. J Crohns Colitis 6: 913–923.
22. SchenkM, BouchonA, SeiboldF, MuellerC (2007) TREM-1-expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases. J Clin Invest 117: 3097–3106.
23. WeberB, SaurerL, SchenkM, DickgreberN, MuellerC (2011) CX3CR1 defines functionally distinct intestinal mononuclear phagocyte subsets which maintain their respective functions during homeostatic and inflammatory conditions. Eur J Immunol 41: 773–779.
24. HaselmayerP, Grosse-HovestL, von LandenbergP, SchildH, RadsakMP (2007) TREM-1 ligand expression on platelets enhances neutrophil activation. Blood 110: 1029–1035.
25. ZanzingerK, SchellackC, NauschN, CerwenkaA (2009) Regulation of triggering receptor expressed on myeloid cells 1 expression on mouse inflammatory monocytes. Immunology 128: 185–195.
26. El MezayenR, El GazzarM, SeedsMC, McCallCE, DreskinSC, et al. (2007) Endogenous signals released from necrotic cells augment inflammatory responses to bacterial endotoxin. Immunol Lett 111: 36–44.
27. WuJ, LiJ, SalcedoR, MivechiNF, TrinchieriG, et al. (2012) The Proinflammatory Myeloid Cell Receptor TREM-1 Controls Kupffer Cell Activation and Development of Hepatocellular Carcinoma. Cancer Res 72: 3977–3986.
28. GibotS, AlauzetC, MassinF, SennouneN, FaureGC, et al. (2006) Modulation of the triggering receptor expressed on myeloid cells-1 pathway during pneumonia in rats. J Infect Dis 194: 975–983.
29. GibotS, MassinF, MarcouM, TaylorV, StidwillR, et al. (2007) TREM-1 promotes survival during septic shock in mice. Eur J Immunol 37: 456–466.
30. Klesney-TaitJ, KeckK, LiX, GilfillanS, OteroK, et al. (2013) Transepithelial migration of neutrophils into the lung requires TREM-1. J Clin Invest 123: 138–149.
31. RadaevS, KattahM, RostroB, ColonnaM, SunPD (2003) Crystal structure of the human myeloid cell activating receptor TREM-1. Structure 11: 1527–1535.
32. TurnbullIR, GilfillanS, CellaM, AoshiT, MillerM, et al. (2006) Cutting edge: TREM-2 attenuates macrophage activation. J Immunol 177: 3520–3524.
33. HumphreyMB, DawsMR, SpustaSC, NiemiEC, TorchiaJA, et al. (2006) TREM2, a DAP12-associated receptor, regulates osteoclast differentiation and function. J Bone Miner Res 21: 237–245.
34. ColonnaM, TurnbullI, Klesney-TaitJ (2007) The enigmatic function of TREM-2 in osteoclastogenesis. Adv Exp Med Biol 602: 97–105.
35. TamoutounourS, HenriS, LelouardH, de BovisB, de HaarC, et al. (2012) CD64 distinguishes macrophages from dendritic cells in the gut and reveals the Th1-inducing role of mesenteric lymph node macrophages during colitis. Eur J Immunol 42: 3150–3166.
36. BainCC, ScottCL, Uronen-HanssonH, GudjonssonS, JanssonO, et al. (2013) Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6C(hi) monocyte precursors. Mucosal Immunol 6: 498–510.
37. SchenkM, BouchonA, BirrerS, ColonnaM, MuellerC (2005) Macrophages expressing triggering receptor expressed on myeloid cells-1 are underrepresented in the human intestine. J Immunol 174: 517–524.
38. CorazzaN, EichenbergerS, EugsterHP, MuellerC (1999) Nonlymphocyte-derived tumor necrosis factor is required for induction of colitis in recombination activating gene (RAG)2(−/−) mice upon transfer of CD4(+)CD45RB(hi) T cells. J Exp Med 190: 1479–1492.
39. NaitoY, TakagiT, HandaO, IshikawaT, NakagawaS, et al. (2003) Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-alpha deficient mice. J Gastroenterol Hepatol 18: 560–569.
40. NotiM, CorazzaN, MuellerC, BergerB, BrunnerT (2010) TNF suppresses acute intestinal inflammation by inducing local glucocorticoid synthesis. J Exp Med 207: 1057–1066.
41. AllenbachC, LaunoisP, MuellerC, Tacchini-CottierF (2008) An essential role for transmembrane TNF in the resolution of the inflammatory lesion induced by Leishmania major infection. Eur J Immunol 38: 720–731.
42. CharmoyM, AudersetF, AllenbachC, Tacchini-CottierF (2010) The prominent role of neutrophils during the initial phase of infection by Leishmania parasites. J Biomed Biotechnol 2010: 719361.
43. Tacchini-CottierF, ZweifelC, BelkaidY, MukankundiyeC, VaseiM, et al. (2000) An immunomodulatory function for neutrophils during the induction of a CD4+ Th2 response in BALB/c mice infected with Leishmania major. J Immunol 165: 2628–2636.
44. WangGG, CalvoKR, PasillasMP, SykesDB, HackerH, et al. (2006) Quantitative production of macrophages or neutrophils ex vivo using conditional Hoxb8. Nat Methods 3: 287–293.
45. FournierBM, ParkosCA (2012) The role of neutrophils during intestinal inflammation. Mucosal Immunol 5: 354–366.
46. CaiM, ChenQ, ChenC, LiuX, HouJ, et al. (2013) Activation of triggering receptor expressed on myeloid cells-1 protects monocyte from apoptosis through regulation of myeloid cell leukemia-1. Anesthesiology 118: 1140–1149.
47. RicheldiL, MarianiM, LosiM, MaselliF, CorbettaL, et al. (2004) Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections. Eur Respir J 24: 247–250.
48. LaglerH, SharifO, HaslingerI, MattU, StichK, et al. (2009) TREM-1 activation alters the dynamics of pulmonary IRAK-M expression in vivo and improves host defense during pneumococcal pneumonia. J Immunol 183: 2027–2036.
49. TatedaK, MooreTA, DengJC, NewsteadMW, ZengX, et al. (2001) Early recruitment of neutrophils determines subsequent T1/T2 host responses in a murine model of Legionella pneumophila pneumonia. J Immunol 166: 3355–3361.
50. SporriR, JollerN, HilbiH, OxeniusA (2008) A novel role for neutrophils as critical activators of NK cells. J Immunol 181: 7121–7130.
51. LeibundGut-LandmannS, WeidnerK, HilbiH, OxeniusA (2011) Nonhematopoietic cells are key players in innate control of bacterial airway infection. J Immunol 186: 3130–3137.
52. DowerK, EllisDK, SarafK, JelinskySA, LinLL (2008) Innate immune responses to TREM-1 activation: overlap, divergence, and positive and negative cross-talk with bacterial lipopolysaccharide. J Immunol 180: 3520–3534.
53. SkerrettSJ, BagbyGJ, SchmidtRA, NelsonS (1997) Antibody-mediated depletion of tumor necrosis factor-alpha impairs pulmonary host defenses to Legionella pneumophila. J Infect Dis 176: 1019–1028.
54. BleharskiJR, KiesslerV, BuonsantiC, SielingPA, StengerS, et al. (2003) A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response. J Immunol 170: 3812–3818.
55. WangF, LiuS, WuS, ZhuQ, OuG, et al. (2012) Blocking TREM-1 signaling prolongs survival of mice with Pseudomonas aeruginosa induced sepsis. Cell Immunol 272: 251–258.
56. HamermanJA, TchaoNK, LowellCA, LanierLL (2005) Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12. Nat Immunol 6: 579–586.
57. TurnbullIR, McDunnJE, TakaiT, TownsendRR, CobbJP, et al. (2005) DAP12 (KARAP) amplifies inflammation and increases mortality from endotoxemia and septic peritonitis. J Exp Med 202: 363–369.
58. VinceJE, WongWW, KhanN, FelthamR, ChauD, et al. (2007) IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell 131: 682–693.
59. Dayer SchneiderJ, SeiboldI, Saxer-SekulicN, ParedesBE, SaurerL, et al. (2009) Lack of TNFR2 expression by CD4(+) T cells exacerbates experimental colitis. Eur J Immunol 39: 1743–1753.
60. TitusRG, MarchandM, BoonT, LouisJA (1985) A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol 7: 545–555.
61. BachmannMF, EcabertB, KopfM (1999) Influenza virus: a novel method to assess viral and neutralizing antibody titers in vitro. J Immunol Methods 225: 105–111.
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2014 Číslo 1
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Human and Plant Fungal Pathogens: The Role of Secondary Metabolites
- Lyme Disease: Call for a “Manhattan Project” to Combat the Epidemic
- Murine Gammaherpesvirus M2 Protein Induction of IRF4 via the NFAT Pathway Leads to IL-10 Expression in B Cells
- Origin, Migration Routes and Worldwide Population Genetic Structure of the Wheat Yellow Rust Pathogen f.sp.